Articles avec mandats d'accès public - Martin GötteEn savoir plus
Non disponibles : 16
Heparanase, hyaluronan, and CD44 in cancers: a breast carcinoma perspective
M Gotte, GW Yip
Cancer research 66 (21), 10233-10237, 2006
Exigences : German Research Foundation
More than matrix: the multifaceted role of decorin in cancer
DDS Feugaing, M Götte, M Viola
European journal of cell biology 92 (1), 1-11, 2013
Exigences : German Research Foundation
Cell-surface heparan sulfate proteoglycans as multifunctional integrators of signaling in cancer
N Hassan, B Greve, NA Espinoza-Sánchez, M Götte
Cellular Signalling 77, 109822, 2021
Exigences : German Research Foundation
Role of cell surface proteoglycans in cancer immunotherapy
NA Espinoza-Sánchez, M Götte
Seminars in cancer biology 62, 48-67, 2020
Exigences : European Commission
Extracellular matrix functions in lung cancer
M Götte, I Kovalszky
Matrix Biology 73, 105-121, 2018
Exigences : European Commission
Syndecan-1, a cell surface proteoglycan, negatively regulates initial leukocyte recruitment to the brain across the choroid plexus in murine experimental autoimmune …
X Zhang, C Wu, J Song, M Götte, L Sorokin
The Journal of Immunology 191 (9), 4551-4561, 2013
Exigences : German Research Foundation
Estrogen receptor beta as epigenetic mediator of miR-10b and miR-145 in mammary cancer
Z Piperigkou, M Franchi, M Goette, NK Karamanos
Matrix Biology 64, 94-111, 2017
Exigences : European Commission
MicroRNA-dependent targeting of the extracellular matrix as a mechanism of regulating cell behavior
SA Ibrahim, H Hassan, M Götte
Biochimica et Biophysica Acta (BBA)-General Subjects 1840 (8), 2609-2620, 2014
Exigences : European Commission
The anti-androgen drug dutasteride renders triple negative breast cancer cells more sensitive to chemotherapy via inhibition of HIF-1α-/VEGF-signaling
MK von Wahlde, C Hülsewig, C Ruckert, M Götte, L Kiesel, C Bernemann
Gynecological Endocrinology 31 (2), 160-164, 2015
Exigences : European Commission
Endocytosis of the dermatan sulfate proteoglycan decorin utilizes multiple pathways and is modulated by epidermal growth factor receptor signaling
DDS Feugaing, R Tammi, FG Echtermeyer, H Stenmark, H Kresse, ...
Biochimie 89 (5), 637-657, 2007
Exigences : German Research Foundation
IL-8 and MCP-1/CCL2 regulate proteolytic activity in triple negative inflammatory breast cancer a mechanism that might be modulated by Src and Erk1/2
HT Mohamed, EA El-Ghonaimy, M El-Shinawi, M Hosney, M Götte, ...
Toxicology and applied pharmacology 401, 115092, 2020
Exigences : US National Institutes of Health, European Commission
In vitro modelling of the physiological and diseased female reproductive system
A Stejskalova, H Vankelecom, M Sourouni, MY Ho, M Goette, BD Almquist
Acta biomaterialia 132, 288-312, 2021
Exigences : UK Engineering and Physical Sciences Research Council
Resveratrol impairs cellular mechanisms associated with the pathogenesis of endometriosis
D Madanes, G Meresman, SA Valla, N Hassan, L Kiesel, B Greve, ...
Reproductive BioMedicine Online 44 (6), 976-990, 2022
Exigences : Government of Argentina
Expression of PRL-3 regulates proliferation and invasion of breast cancer cells in vitro
I Radke, M Götte, M Smollich, N Scharle, L Kiesel, P Wülfing
Archives of gynecology and obstetrics 296, 1153-1160, 2017
Exigences : European Commission
Enzymatic digestion of cell-surface Heparan sulfate alters the radiation response in triple-negative breast cancer cells
SL Krautschneider, FM Troschel, E Vadillo, HT Eich, M Götte, ...
Archives of Medical Research 53 (8), 826-839, 2022
Exigences : German Research Foundation
Nanocapsule induced morphology and migration changes in single cell layers quantified with digital holographic microscopy
M Kaiser, L Pohl, S Ketelhut, L Kastl, C Gorzelanny, M Götte, ...
Quantitative Phase Imaging V 10887, 137-142, 2019
Exigences : Federal Ministry of Education and Research, Germany
Disponibles quelque part : 88
Therapeutic value of glycosaminoglycans in cancer
GW Yip, M Smollich, M Gotte
Molecular cancer therapeutics 5 (9), 2139-2148, 2006
Exigences : German Research Foundation
Syndecan-1 is a novel molecular marker for triple negative inflammatory breast cancer and modulates the cancer stem cell phenotype via the IL-6/STAT3, Notch and EGFR signaling …
SA Ibrahim, R Gadalla, EA El-Ghonaimy, O Samir, HT Mohamed, ...
Molecular cancer 16, 1-19, 2017
Exigences : European Commission
Differential roles for membrane-bound and soluble syndecan-1 (CD138) in breast cancer progression
V Nikolova, CY Koo, SA Ibrahim, Z Wang, D Spillmann, R Dreier, ...
Carcinogenesis 30 (3), 397-407, 2009
Exigences : German Research Foundation
Roles and targeting of the HAS/hyaluronan/CD44 molecular system in cancer
E Karousou, S Misra, S Ghatak, K Dobra, M Götte, D Vigetti, A Passi, ...
Matrix Biology 59, 3-22, 2017
Exigences : US National Institutes of Health
Les informations concernant la publication et le financement sont déterminées automatiquement par un programme informatique